Anti-tuberculosis drug can be safely dosed even higher

(Radboud University Medical Center) A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance. This is what researchers from Radboud university medical center in Nijmegen, the Netherlands, write in a recent publication. With this they complete a year-long search for the right dosing of an old drug against tuberculosis that appears to be the key drug.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news